Sai Life Sciences Limited (NSE:SAILIFE)
India · Delayed Price · Currency is INR 1,457.40
-14.20 (-0.96%)
Aug 21, 2026, 3:30 PM IST
Sai Life Sciences Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Sai Life Sciences stock has a consensus rating of "Buy" and an average price target of ₹1,553. The average 1-year stock price forecast is 6.54% higher than the current stock price, while the lowest is ₹1,450 (-0.51%) and the highest is ₹1,610 (+10.47%).
Price Target: ₹1,553 (+6.54%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Sai Life Sciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Maintains ₹1,270 → ₹1,610 | Buy | Maintains | ₹1,270 → ₹1,610 | +10.47% | Aug 12, 2026 |
Financial Forecast
Revenue This Year
26.27B
from 21.92B
Increased by 19.80%
Revenue Next Year
31.64B
from 26.27B
Increased by 20.48%
EPS This Year
19.81
from 16.76
Increased by 18.21%
EPS Next Year
24.98
from 19.81
Increased by 26.12%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.